Abstract Rheumatoid arthritis (RA) is characterized by the interaction of multiple mediators, among the most important of which are cytokines.
Introduction
Rheumatoid arthritis (RA) is a chronic and debilitating autoimmune disease characterized by inflammation and destruction of synovial joints. The affected joints display inflammatory infiltration by neutrophils, macrophages, T cells and dendritic cells; persistent pro-inflammatory cytokine production and complement deposition; formation of a hyperplastic and invasive pannus; and erosion and remodeling of cartilage and bone [1] . It has been difficult to study the initial stages of disease because individuals are diagnosed only after joint inflammation becomes established. Animal models of arthritis in which disease can be induced in a synchronized fashion thus allow for the investigation of the role of specific cell types and effector molecules to the pathologic steps leading to disease.
The cytokine known as macrophage migration inhibitory factor (MIF) is becoming increasingly recognized for its upstream role in regulating the immune and inflammatory response. While the original description of this mediator focused on its ability to arrest macrophage migration, MIF is now known to be released by diverse cell types including macrophages and to upregulate activation responses by specific signal transduction and antiapoptotic pathways [2] [3] [4] . Within the RA synovium, MIF is expressed by macrophages, CD4? T cells and fibroblast-like synoviocytes (FLS). FLS-derived MIF upregulates the release of monocyte tumor necrosis factor (TNF-a), suggesting that MIF acts in a paracrine ''feed-forward'' manner to sustain the pro-inflammatory cytokine network within rheumatoid synovium [5] . MIF also activates FLS expression of key pro-inflammatory mediators, such as prostaglandin E 2 via induction of phospholipase A 2 and cyclooxygenase-2 expression [6] ; the cytokines IL-1, IL-6 and IL-8; and the matrix metalloproteases involved in cartilage destruction [7] [8] [9] . Synovial leukocyte trafficking also has been demonstrated to be impaired in the absence of MIF [10] . MIF also enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis [11] . Mikulowska et al. [12] first explored the role of MIF in joint inflammation by studying murine collagen-induced arthritis: Treatment with a neutralizing anti-MIF antibody before immunization with type II collagen led to delayed onset and lowered frequency of arthritis. Leech et al. [13] subsequently reported that anti-MIF monoclonal antibody administration produced a dramatic reduction in clinical and histological parameters of disease in the rat adjuvant arthritis. The progression of antigen-induced arthritis also was profoundly inhibited by immunoneutralization or genetic deficiency of MIF [14] . Of note, recent genetic studies in RA patients have shown a significant relationship between high-expression MIF alleles and more severe, erosive disease [15] . MIF plays a role in chemotactic neutrophil recruitment [16] and T cell activation regulating ERK MAP kinase phosphorylation [17] in arthritis. Also, MIF has been recently shown to be critical in Ross River virus-induced arthritis [18] .
In this study, we analyzed the impact of genetic MIF deficiency in the K/BxN serum transfer model of arthritis [19] , in which joint damage is strictly dependent on macrophages and ensues in the absence of T or B cell-mediated pathways [20, 21] . We also studied the role of macrophage production of MIF in reconstitution studies employing wild-type macrophages. MIF -mice were protected from serum-induced arthritis and showed a significant decrease in serum interleukin-1b (IL-1 b) and IL-6 levels; however, the adoptive transfer of wild-type, MIF-producing macrophages to MIF -mice produced an arthritis that was indistinguishable from that which developed in wild-type mice.
Methods

Experimental animals
KRN TCR-transgenic mice on the C57BL/6 background [19] were a kind gift from Drs. D. Mathis and C. Benoist (Strasbourg, France) and were crossed to NOD/Lt (N) mice to generate K/BxN mice. MIF-deficient mice maintained on a pure C57BL/6 background have been described previously [22] . C57BL/6 mice were obtained from Charles River Laboratories, Sulzfeld, Germany. All mice were maintained under pathogen-free conditions and bred at the animal facility of the University of Applied Sciences, Rheinbach, Germany. All mice were sex-and age-matched for experiments and were between 8 and 10 weeks of age. Animal experimentation was performed in accordance with local guidelines and with permission of the ethical committee.
Preparation of K/BxN arthritogenic serum
The K/BxN progenies bearing the Vb6-transgenic TCR were identified by flow cytometry of peripheral blood lymphocytes using anti-CD4-PE-and anti-Vb6-FITClabeled mAb (BD PharMingen, Heidelberg, Germany). Serum was separated from the blood obtained from tail sampling of arthritic mice; these were pooled and frozen at -20°C until use. Arthritis was induced in mice by intraperitoneal (i.p.) injection of 200 ll equivalent of serum from K/BxN or control mice.
Clinical and histological assessment of arthritis Ankle thickness (mm) was measured with a caliper, and clinical scores were determined on alternate days upon evidence of redness and swelling using a scale ranging from 0 to 4 as described (14) . Arthritis was assessed visually as the clinical index score, where 1 = one ankle affected, 2 = two ankles affected, 3 = three ankles affected and 4 = all four ankles affected.
Samples for histological analysis were prepared by fixing the paws with ankle joints for 24-48 h in 4 % phosphatebuffered formaldehyde (Sigma Aldrich, Deisenhofen, Germany). Fixed joints were decalcified by treatment with 14 % EDTA solution (Merck KGgA, Darmstadt, Germany) for 2 weeks with gentle rocking and daily replacement of the solution. Samples were then washed with PBS, dehydrated with a series of ethanol washes (50 % ethanol, followed by 70, 95 and 100 % ethanol) and embedded in paraffin. Fourmicrometer-thick sections of tissue were stained with hematoxylin/eosin, and histological evaluation of inflammation and joint destruction was performed in a blinded fashion. The extent of joint inflammation was defined by synovial hyperplasia and degree of infiltration of the synovial tissue with polymorphonuclear and mononuclear leukocytes as follows: 0 = no changes; 1 = mild hyperplasia and infiltration; 2 = moderate changes; and 3 = severe changes. The extent of damage of the cartilage surface and bone structures was evaluated on a scale of 0-3, where 0 = no damage, 1 = mild destruction, 2 = moderate destruction and 3 = severe destruction of cartilage and bone (extensive area of cartilage destruction, deep invasive bone erosions).
Macrophage preparation and reconstitution of MIF -mice Peritoneal macrophages were isolated from 6-to 8-week-old wild-type or MIF -mice (both in the C57BL/6 background). Five to eight milliliters of ice-cold PBS was injected intraperitoneally, the mice were euthanized by cervical dislocation, and the cells in the peritoneal fluid were collected. After centrifugation of the peritoneal exudate, the cells were resuspended in PBS. Macrophages were then purified by adherence on 90-mm-diameter culture dishes (Greiner, Frickenhausen, Germany) for 1 h in 5 % CO 2 at 37°C, and the non-adherent cells, which were mainly lymphocytes, were removed by washing two times with warm PBS. The adherent macrophages were then collected and resuspended in PBS, and 1.5 9 10 7 cells (in a total volume of 0.2 ml) were injected intraperitoneally into recipient MIF -mice.
Quantification of cytokines by Luminex methodology and ELISA
Mouse sera were diluted 1:3 with sera dilute (Bio-Rad), and cytokines (with the exception of MIF) were quantified using a bead-based multiplex assay on a Bio-Plex Luminex analyzer (Bio-Rad) according to manufacture's protocol. Data were analyzed using Graphpad Prism version 4.00 for Windows (GraphPadSoftware, San Diego, CA, USA). For the measurement of MIF, sera were diluted 1:3 with 19 reaction buffer (0.1 % BSA-1 mM EDTA-0.05 % Tween 20-PBS) and subjected to a murine-specific MIF ELISA as described previously [21] . For the quantification of synovial cytokine content, mouse ankle joints were frozen in liquid nitrogen and ground into the powder (60 s) using Mikro Dismembrator (B. Braun Biotech International, Germany). The powder was then suspended in 400 ll of lysis buffer (10 ml RIPA buffer, 1 tablet of protease inhibitor cocktail from Roche Diagnostics, Mannheim, Germany) and incubated on ice for 1 h. The homogenate was centrifuged at 1,8709g for 15 min, and the resulting supernatant was centrifuged again at 13,2309g for 5 min. Each supernatant was then adjusted to 40 mg protein/ ml using the Bio-Rad protein assay reagent. Fifty microliters of supernatant was then utilized for cytokine determination by Luminex assay or in the case of MIF, by ELISA. Values were expressed relative to total tissue protein.
Statistical analysis
Statistical significance was analyzed using the Graphpad Prism software. Data are expressed as mean ± SEM. Comparisons were performed using the unpaired Student's t test or the MannWhitney U-test and by analysis of variance. Differences were considered statistically significant when P \ 0.05.
Results
MIF-deficient mice are protected from K/BxN serum-induced arthritis
MIF
-and wild-type control (C57BL/6) mice were injected i.p. with 200 ll of K/BxN sera at day 0. The wild-type controls showed the clinical signs and symptoms of arthritis that are typical of this model (Fig. 1) . Ankle swelling in the wild-type mice was evident beginning at day 2 after serum injection, with peak swelling measured at days 7 and 8, after which disease began to resolve. By contrast, MIF -mice were resistant to the development of arthritis and showed significantly decreased joint disease after serum injection, as assessed by ankle thickness (Fig. 1a) and the clinical index score (Fig. 1b) .
To more accurately determine the degree of inflammation and destruction of cartilage and bone, sections of ankle joints were examined and graded using a histopathologic scoring system. Joint swelling and the clinical severity of arthritis were higher in wild-type mice when compared to MIF -mice (day 8; inflammation score 4.0 ± 0.5 in wildtype mice, 1.0 ± 0.5 in MIF -mice, P \ 0.0004; destruction score 0.9 ± 0.5 in wild-type mice, 0.2 ± 0.5 in MIF -mice, P \ 0.0043) (Fig. 2) . Histologic evaluation of joints from the wild-type mice revealed the exudation of polymorphonuclear leukocytes into the joint space, hyperplasia of the synovial lining layer, infiltration of inflammatory cells into the synovial tissue and expansion of synovial tissue (pannus) over the articular cartilage surface with degradation of the cartilage and erosion of the bone (Fig. 3) . By contrast, the joints of MIF -mice showed no visible evidence of cartilage or bone erosion, or cellular proliferation, and there was scant infiltration by inflammatory cells.
Reconstitution of MIF-deficient mice with wild-type macrophages restores susceptibility to arthritis While MIF is produced upon the inflammatory activation of a number of different cell types, early studies of lethal endotoxemia suggested that the macrophage is an important Rheumatol Int (2013) 33:2301-2308 2303 source of MIF in vivo [2] . We tested the hypothesis that macrophage-derived MIF is important for the pathogenesis of K/BxN serum-induced arthritis by adoptively transferring 1.5 9 10 7 peritoneal-derived, wild-type macrophages into MIF -mice. Wild-type mice injected with PBS alone and MIF -mice injected with MIF -macrophages also were studied in parallel for arthritis development.
The wild-type macrophage-reconstituted MIF -mice were observed to be fully susceptible to arthritis induction upon K/BxN serum transfer, as evident from the ankle thickness and clinical index scores (Fig. 4) . The typical features of K/BxN serum-induced arthritis were manifested with a peak in joint swelling at days 5-7, which then decreased at days 9-11. No significant differences in the histological evaluation of inflammation (P \ 0.64) or cartilage and bone destruction (P \ 0.47) were evident upon comparison of wild-type animals with MIF -mice reconstituted with wild-type macrophages (Fig. 4c) . Microscopic examination of joints also confirmed that the wild-type macrophage-reconstituted MIF -mice showed the classic histological picture of inflammatory cell infiltration and pannus invasion into cartilage (Fig. 4d) . No difference in arthritis was observed upon K/BxN serum administration to MIF -mice injected with MIF -macrophages when compared to MIF -mice alone (data not shown). The restoration of inflammatory joint pathology by the reconstitution of MIF -mice with wild-type peritoneal macrophages supports the conclusion that macrophage-derived MIF is necessary for the full development of K/BxN serum-induced arthritis.
Serum inflammatory mediators IL-1b and IL-6 levels are reduced in MIF -mice but restored in MIF -mice reconstituted with wild-type peritoneal macrophages Serum levels of the cytokines IL-1b, TNF-a, IL-6, MCP-1, IL-12 (p40) and IL-10 were measured following the administration of K/BxN serum to wild-type mice, MIF -mice, MIF -mice reconstituted with wild-type macrophages and MIF -mice reconstituted with MIF -macrophages. Serum was isolated from mice on days 3 and 8 after arthritis induction (Fig. 5) . Both wild-type mice and -mice compared to the wild-type mice (P \ 0.0004 and P = 0.004, respectively). Bars show the mean ± SEM. P values were determined using the Mann-Whitney U-test
-mice injected with wild-type macrophages showed significantly higher serum levels of IL-1b and IL-6 on days 3 and 8 post-arthritis induction when compared with MIF -mice (or MIF -mice reconstituted with MIF -macrophages) (P \ 0.05 vs. MIF -mice). No changes in the circulating levels of TNF-a, MCP-1, IL-12(p40) or IL-10 were detected in the different experimental groups. The ELISA measurement of the intrasynovial concentration of these cytokines showed very low overall values, although a time-dependent increase in IL-1b, IL-6, IL-12 and MCP-1 could be detected (data not shown). There were no statistically significant differences in the synovial tissue content of cytokines between the different experimental groups, which likely reflects the low sensitivity of this analysis, although a trend for increased intrasynovial IL-6 in MIF -mice reconstituted with WT macrophage versus MIF -mice was detected (P \ 0.06) (data not shown).
We also measured the levels of MIF on day 8 after arthritis induction. While MIF was detectable in the serum (1.8 ng/ml) and the joint tissue (1.9 ng/mg tissue) of wild-type mice with arthritis, MIF levels remained undetectable in the serum or joint tissue of MIF -mice or MIF -mice reconstituted with wild-type macrophages (data not shown).
Discussion
The cytokine profile of RA synovium is an area of intense research interest, with respect to both the particular cytokines that initiate joint inflammation and those that mediate joint destruction. Pro-inflammatory cytokines such as TNFa and IL-1b have been shown to induce in vitro many of the mediators of inflammation and joint injury that are expressed in RA. A closer understanding of the role of these cytokines in the immunopathology of RA also has led to the development of effective therapeutic strategies. Yet, even with pharmacologic inhibition of TNF, as many as 40 % of RA patients show an inadequate clinical response [23] . Furthermore, current anticytokine strategies have not proved curative, and the search for better therapeutic targets in RA continues. Considerable evidence suggests a role for MIF in the pathogenesis of RA, including attenuation of disease parameters in animal models in the setting of MIF neutralization or deficiency [13, 24, 25] , overexpression of MIF in human RA [26] , activating effects of MIF on human RA synovial fibroblasts [6, 26] and association of a MIF gene polymorphism with the progression of erosion in RA [15] . MIF serum levels are associated with RA course, clinical activity and clinical biomarkers of the disease [27] . Macrophages are present in high numbers in inflamed synovium and at the cartilage-pannus interface in RA, and they have been shown to play a crucial role in the K/BxN serum-induced model of arthritis [20] . The data presented here demonstrate an important role for MIF in the We show here that an arthritis-susceptible phenotype is restored in MIF -mice by the adoptive transfer of wild-type macrophages, indicating an important role for macrophagederived MIF in the pathogenesis of joint inflammation. This finding also suggests that a systemic, macrophagereleased MIF is sufficient to initiate the cytokine cascade responsible for the inflammatory infiltration of joints, the formation of invasive pannus, and cartilage and bony destruction. Previously, it has been shown [28] that MIF, released by macrophages upon recognition of immune complexes, is critical to inflammation in the Arthus reaction. Arthritis in MIF -mice was associated with significantly decreased serum IL-1b and IL-6 levels, whereas the levels of these cytokines were restored in MIF -mice reconstituted with wild-type macrophages. TNF-a levels in serum and joint tissue were not found to differ between wild-type and MIF -mice (or MIF -mice reconstituted with wild-type macrophages), despite marked differences in joint pathology. That TNF-a levels were not influenced by the reconstitution of MIF -mice with wild-type macrophages also supports the conclusion that the inflammatory cascade induced by arthritogenic K/BxN serum proceeds independently of TNF-a. These data are in accord with those studies that have shown that TNF -mice display a variable response to K/BxN serum-induced arthritis and that the presence of TNF receptor types I and II is not essential for immunopathology [29] . However, IL-1 b is required for the development of K/BxN serum transfer arthritis [30] , and our data suggest that serum IL-1b (and IL-6) expression not only depends on the presence of MIF, but that a systemic MIF response provided by adoptively transferred macrophages is sufficient to restore IL-1b-independent and IL-1b-dependent effector responses. We did not detect significant differences in the synovial content of cytokines, which likely reflects the low sensitivity of the joint tissue ELISA measurements. These data nevertheless point to the dominant influence of adoptively transferred, macrophage-derived MIF on systemic cytokine expression, which was more readily detectable and may contribute importantly to arthritis development.
In conclusion, deletion of MIF resulted in inhibition of joint inflammation and joint destruction induced by K/BxN serum. We also show that macrophage-derived MIF, as provided by systemically administered peritoneal macrophages, is necessary to drive the full arthritis development. These results support the hypothesis that MIF is an important, upstream mediator leading to inflammatory joint disease and further suggest that the pharmacologic targeting of MIF may offer a unique therapeutic target in those RA patients unresponsive to TNF inhibitors.
